Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
  1. 4 Grant or award CEO acquired 81,250 shares (grant or award)
  2. 4 Grant or award Director acquired 273,750 shares (grant or award)
  3. 4 Exercise or conversion CEO acquired 697,500 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 50,000 shares at an average $1.90 ($95,001)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award CFO acquired 41,666 shares (grant or award)
  10. 4 Grant or award Director acquired 14,634 shares (grant or award)
  11. 4 Grant or award Director acquired 35,000 shares (grant or award)
  12. 4 Grant or award CEO acquired 29,475 shares (grant or award)
  13. 4 Grant or award Director acquired 32,433 shares (grant or award)
  14. 4 Grant or award CEO acquired 210,000 shares (grant or award)
  15. 4/A Grant or award Director acquired 35,294 shares (grant or award)
  16. 4 Grant or award President acquired 210,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Director acquired 35,249 shares (grant or award)
  19. 4 Grant or award Director acquired 29,091 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 7 of 21 · 420 filings